Vectors Research Management’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-135
Closed -$31K 484
2021
Q4
$31K Buy
+135
New +$28.7K 0.01% 300
2020
Q4
Sell
-4
Closed -$1K 441
2020
Q3
$1K Sell
4
-218
-98% -$38.4K ﹤0.01% 406
2020
Q2
$42K Hold
222
0.02% 183
2020
Q1
$39K Sell
222
-53
-19% -$10.3K 0.02% 181
2019
Q4
$56K Hold
275
0.02% 171
2019
Q3
$42K Hold
275
0.02% 180
2019
Q2
$43K Sell
275
-48
-15% -$7.52K 0.02% 174
2019
Q1
$52K Hold
323
0.03% 158
2018
Q4
$61K Buy
+323
New +$67.4K 0.03% 175

Other funds holding CI

Vectors Research Management's CI Position: Q1 2022 in Review

Vectors Research Management sold out of Cigna (CI) in Q1 2022, closing a stake of 135 shares — an estimated $31K sold.

Vectors Research Management first reported a position in CI in Q4 2018 and held it in 9 quarters. The position peaked at $61K in Q4 2018. 1,375 funds tracked by Wall St. Rank hold CI as of Q1 2022.

  • Vectors Research Management reported no remaining Cigna position as of Q1 2022 after selling out during the quarter.
  • Vectors Research Management sold 135 Cigna shares in Q1 2022, an estimated $31K.
  • Vectors Research Management first reported a position in Cigna in Q4 2018 and held it in 9 quarters.
  • Vectors Research Management's Cigna position peaked at $61K in Q4 2018.
  • 1,375 funds tracked by Wall St. Rank held Cigna as of Q1 2022.

Based on Vectors Research Management's 13F filing for Q1 2022, filed 16 May 2022.